AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 110 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,125,000 | +152.6% | 150,000 | +66.7% | 0.65% | +121.1% |
| Q1 2015 | $2,821,000 | +9.2% | 90,000 | +1.7% | 0.29% | -33.2% |
| Q4 2014 | $2,584,000 | -23.6% | 88,516 | -45.9% | 0.44% | +5.3% |
| Q3 2014 | $3,383,000 | +24.1% | 163,516 | +48.7% | 0.42% | -37.8% |
| Q2 2014 | $2,725,000 | +14.3% | 110,000 | -2.2% | 0.67% | +23.5% |
| Q1 2014 | $2,384,000 | +20.6% | 112,500 | +2.3% | 0.54% | -1.1% |
| Q4 2013 | $1,976,000 | – | 110,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |